Cibc World Market Inc. Vertex Pharmaceuticals Inc Transaction History

Cibc World Market Inc.

$43.4 Billion
Q2 2024

A detailed history of Cibc World Market Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cibc World Market Inc. holds 13,421 shares of VRTX stock, worth $6.74 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,421

Previous 11,777 13.96%

Holding current value

$6.74 Million

Previous $4.92 Million 27.79%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$392.81 - $485.53 $645,779 - $798,211	1,644 Added 13.96%	13,421 $6.29 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $565,058 - $618,266	1,386 Added 13.34%	11,777 $4.92 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $740,194 - $886,247	2,158 Added 26.21%	10,391 $4.23 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $1.64 Million - $1.76 Million	-4,861 Reduced 37.12%	8,233 $2.86 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $3.29 Million - $3.68 Million	10,464 Added 397.87%	13,094 $4.61 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $323,165 - $368,657	-1,141 Reduced 30.26%	2,630 $829,000
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $114,018 - $128,270	399 Added 11.83%	3,771 $1.09 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $258,495 - $288,420	-944 Reduced 21.87%	3,372 $976,000
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $541,817 - $674,620	-2,306 Reduced 34.82%	4,316 $1.22 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $600,712 - $708,011	2,713 Added 69.4%	6,622 $1.73 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $691,932 - $873,466	3,909 New	3,909 $858,000
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $255,548 - $301,359	-1,363 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $77,218 - $90,008	373 Added 37.68%	1,363 $293,000
Q4 2020 Feb 08, 2021	SELL	$207.01 - $276.09 $327,075 - $436,222	-1,580 Reduced 61.48%	990 $234,000
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $9,970 - $11,820	-39 Reduced 1.49%	2,570 $699,000
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $3.45 Million - $4.53 Million	-15,312 Reduced 85.44%	2,609 $757,000
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $199,570 - $247,562	-999 Reduced 5.28%	17,921 $4.26 Million
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $3.15 Million - $4.24 Million	18,920 New	18,920 $4.14 Million
Q2 2019 Aug 08, 2019	SELL	$164.61 - $190.37 $2.19 Million - $2.53 Million	-13,279 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$163.73 - $194.7 $1.59 Million - $1.89 Million	9,697 Added 270.71%	13,279 $2.44 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $75,955 - $96,105	-500 Reduced 12.25%	3,582 $594,000
Q3 2018 Nov 09, 2018	BUY	$167.73 - $192.74 $463,270 - $532,347	2,762 Added 209.24%	4,082 $787,000
Q2 2018 Aug 08, 2018	SELL	$145.72 - $169.96 $77,668 - $90,588	-533 Reduced 28.76%	1,320 $224,000
Q1 2018 May 18, 2018	BUY	$151.6 - $177.13 $280,914 - $328,221	1,853 New	1,853 $302,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Vertex Pharmaceuticals Inc Transaction History